PH22279A - Benzo(c)-1,5-naphthyridines - Google Patents

Benzo(c)-1,5-naphthyridines

Info

Publication number
PH22279A
PH22279A PH33508A PH33508A PH22279A PH 22279 A PH22279 A PH 22279A PH 33508 A PH33508 A PH 33508A PH 33508 A PH33508 A PH 33508A PH 22279 A PH22279 A PH 22279A
Authority
PH
Philippines
Prior art keywords
loweralkyl
diarylloweralkyl
arylloweralkyl
chem
naphthyridines
Prior art date
Application number
PH33508A
Other languages
English (en)
Inventor
Lawrence L Martin
Linda L Setescak
Susan J Scott
Original Assignee
Hoechst Roussel Phamaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Phamaceuticals filed Critical Hoechst Roussel Phamaceuticals
Publication of PH22279A publication Critical patent/PH22279A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
PH33508A 1985-03-13 1986-03-11 Benzo(c)-1,5-naphthyridines PH22279A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/711,327 US4652567A (en) 1985-03-13 1985-03-13 Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement

Publications (1)

Publication Number Publication Date
PH22279A true PH22279A (en) 1988-07-14

Family

ID=24857642

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33508A PH22279A (en) 1985-03-13 1986-03-11 Benzo(c)-1,5-naphthyridines

Country Status (19)

Country Link
US (1) US4652567A (da)
EP (1) EP0197318B1 (da)
JP (1) JPS61212585A (da)
KR (1) KR860007255A (da)
AT (1) ATE52510T1 (da)
AU (1) AU590748B2 (da)
CA (1) CA1248108A (da)
DE (1) DE3671017D1 (da)
DK (1) DK114386A (da)
ES (4) ES8707528A1 (da)
FI (1) FI861001A (da)
GR (1) GR860681B (da)
HU (2) HU197007B (da)
IL (1) IL78117A0 (da)
NO (1) NO163489B (da)
NZ (1) NZ215439A (da)
PH (1) PH22279A (da)
PT (1) PT82187B (da)
ZA (1) ZA861837B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766217A (en) * 1984-01-13 1988-08-23 Boehringer Ingelheim Kg Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
US5994367A (en) 1997-03-07 1999-11-30 The University Of North Carolina At Chapel Hill Method for treating tumors using 2-aryl-naphthyridin-4-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2273533A1 (fr) * 1974-06-04 1976-01-02 Ferlux Sa Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5
US4297358A (en) * 1979-01-16 1981-10-27 Ciba-Geigy Corporation Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine

Also Published As

Publication number Publication date
EP0197318A1 (en) 1986-10-15
HUT40658A (en) 1987-01-28
FI861001A0 (fi) 1986-03-11
DE3671017D1 (de) 1990-06-13
ES8801269A1 (es) 1988-01-01
DK114386A (da) 1986-09-14
US4652567A (en) 1987-03-24
PT82187A (en) 1986-04-01
AU590748B2 (en) 1989-11-16
ES8801270A1 (es) 1988-01-01
AU5465886A (en) 1986-09-18
HU197007B (en) 1989-02-28
KR860007255A (ko) 1986-10-10
HU201756B (en) 1990-12-28
DK114386D0 (da) 1986-03-12
ES557208A0 (es) 1987-12-01
PT82187B (en) 1988-01-07
IL78117A0 (en) 1986-07-31
GR860681B (en) 1986-07-14
NO860933L (no) 1986-09-15
ES557768A0 (es) 1988-01-01
EP0197318B1 (en) 1990-05-09
NZ215439A (en) 1990-03-27
NO163489B (no) 1990-02-26
ZA861837B (en) 1987-06-24
CA1248108A (en) 1989-01-03
ES552874A0 (es) 1987-08-01
ATE52510T1 (de) 1990-05-15
ES557207A0 (es) 1988-01-01
ES8800941A1 (es) 1987-12-01
JPS61212585A (ja) 1986-09-20
ES8707528A1 (es) 1987-08-01
FI861001A (fi) 1986-09-14

Similar Documents

Publication Publication Date Title
NZ221543A (en) 4-aminoquinoline derivatives and pharmaceutical compositions containing such
GR3019468T3 (en) 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
PL294221A1 (en) Method of obtaining novel 1-pyrido (3,4-b)-1,4-oxazinyl-4-ilo)-1h-indoles
EP0273176A3 (en) Fused heterocyclic tetrahydroaminoquinolinols and related compounds, a process for their preparation and their use as medicaments
PH22279A (en) Benzo(c)-1,5-naphthyridines
IL99168A0 (en) 1-(pyridinylalkyl-1h-indoles,indolines and related analogs
NO911998D0 (no) Pyrido(3,4-b)(pyrrolo(1,2-e)(1,4,5)oksadiazepin og beslektede analoger og fremgangsmaate for fremstilling derav.